Print

Synta Pharmaceuticals Announces Presentations at the 2013 Annual Meeting of the American Association for Cancer Research  
4/8/2013 6:32:10 AM

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that poster presentations related to studies with ganetespib, a selective Hsp90 inhibitor in clinical development by the company, will be presented at the 2013 Annual Meeting of the American Association of Cancer Research in Washington, D.C. Presentations include:

Inhibition of mTOR enhances the activity of HSP90 inhibitors in part through cessation of heat shock protein synthesis

//-->